Cancer is Personal

There are 15 million Americans are living with cancer – yet, on average, only 25% of patients will benefit from the offered treatment.1 What if you could take steps to improve that statistic?

GPS Cancer can help oncologists select a treatment plan by studying the unique biology of each patient’s tumor. Cancer is personal, and in the era of precision medicine, a treatment plan can be too.

Know Cancer—Down to Its DNA

More information can mean better outcomes for you and your patients. GPS Cancer offers a comprehensive set of molecular profiling and decision support solutions that equip oncologists with actionable insights. Get to know your patients’ cancer—down to its DNA—to inform targeted, evidence-based treatment strategies.


41% of Americans will be diagnosed with cancer in their lifetime.2

Saving Money, Time, and Lives

The Era of Precision Medicine is Here

We provide tools that can help you give your patients better treatments—and potentially better chances. With Precision Insights, you can:

References: 1 Cancer Principles and Practice of Oncology. 6th Edition DeVita, et al. Lippincott Williams and Wilkin, 2 “41 percent of Americans will get cancer.” United Press International. May 6, 2010.